S. Tucson firm creates self-cleansing technology
xG offers solutions that are applicable in numerous industries worldwide, including urban and rural wireless broadband, utilities, defense, emergency response and public safety. Based in Sarasota, Florida, xG has over 60 U.S and over 140 international patents and pending patent applications, and its technology is available for licensing in both domestic and foreign markets. xG is a publicly traded company listed on the NASDAQ Capital Market and on the London Stock Exchange’s Alternative Investment Market (AIM). On the NASDAQ, xG common stock is traded under the symbol XGTI and xG warrants are traded under the symbol XGTIW. On the AIM, xG’s unrestricted shares trade under the stock symbol XGTU.L and xG’s restricted ‘Reg S’ shares trade under the stock symbol XGT.L. For more information, please visit http://www.xgtechnology.com. Cautionary Statement Regarding Forward Looking Statements Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to xG Technology, Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
For the original version including any supplementary images or video, visit http://www.marketwatch.com/story/xg-technology-announces-closing-of-over-allotment-option-for-recent-initial-public-offering-2013-08-19
O’Neil, who is well-known in the Chicago tech scene in his own right. Recognized as a co-founder of EveryBlock ( R.I.P. ) and the person who helped spearhead much of Chicago’s open data initiatives , Dan and I were able to combine forces to put together the kind of tech curriculum that public high school students are rarely exposed to. (I attended a public high school myself out in suburban Chicago, which itself had infinite resources compared to the students in the Chicago Public School system. Still, we barely had what http://www.spectator.co.uk/features/8789231/alpha-male/ one might consider to be a “modern” tech education.) Dan had some ideas about where he wanted the curriculum to go, and he put me in charge of developing it into something we could teach over the course of the summer. This being the first time such a program had been put together here in Chicago, there were, unsurprisingly, some bumps in the road. But now that the program is over and school is on the verge of starting again, we feel confident looking back and saying that the first Civic Innovation Summer was a success, and we look forward to improving on it with the goal of reaching even more students in the future. So what did we learn? First, I should probably discuss what we ended up teaching. Part of the goal of Smart Chicago heading up to Civic Innovation Summer (or as we’ve been calling it with the youth, #civicsummer) was to make the curriculum itself open: open to the students, open to the public, open to other organizations.
For the original version including any supplementary images or video, visit http://arstechnica.com/staff/2013/08/teaching-150-teenagers-the-basics-of-technology-in-6-weeks/
Aecom Technology Larger Than S&P 500 Component J.C. Penney
The company makes a variety of hazmat suits, some with special seaming and zippers to keep users safe even from gaseous hazards. We can keep the hazards away from the wearer, but at some point, hes going to have to take that suit off, Cole said, citing the danger to workers from hazards that cling to their suits. Cole said hes confident the technology works, though it will be at least a year before it starts showing up as the first reactive technology in Kapplers products. The company also is working to incorporate its germ-busting technology into medical face masks, to help stem the problem of hospital-acquired infections, Lombardi said. UA professor Charles Gerba, a noted expert on germ transmission who has tested Ventanas antimicrobial technology, said it is notable for the broad spectrum of pathogens it can kill off. In testing on hard surfaces about two years ago, Gerbas research showed the product killed 99.99 percent of a particular pneumonia bacterium within 10 minutes. It showed a 96 to 98 percent reduction in spores from a bacterium often used as a surrogate for deadly anthrax, and an 88 to 92 percent reduction in Methicillin-resistant Staphylococcus aureus (MRSA). Its very difficult to kill things in a broad spectrum, said Gerba, who has tested antimicrobial materials for a number of companies. For their size, they seem to be really creative, he said of Ventana. Lombardi also sees great opportunity in consumer markets, where antimicrobial materials started showing up several years ago in bathroom, kitchen and personal products.
For the original version including any supplementary images or video, visit http://azstarnet.com/business/local/s-tucson-firm-creates-self-cleansing-technology/article_26c6a794-5c82-54be-b637-1adf898e3f17.html
Forward Technology Festival draws entrepreneurs to Madison
“What’s important is that the Forward Technology Festival is really just a canvas and it’s up to the rest of the organizations to come together and paint the picture of this year’s festival the way they want to,” said Matt Younkle, founder of Murfie.com and a Capital Entrepreneurs co-founder. The format helps ensure that session topics are current and that new organizations have the chance to be involved, Younkle said. The festival attracts attendees from around the Midwest, and some have attracted international participants, Younkle said. The festival’s growth parallels the growth in the last few years of Madison’s entrepreneurial community, said Zach Brandon, president of the Greater Madison Chamber of Commerce. Capital Entrepreneurs has grown from a handful of members to at least 200. Madison now has at least four new co-working spaces where technologists can pay a monthly fee for tools and collaboration opportunities, and technology firms including Google and Zendesk are expanding their presences in Madison, Brandon said. Most Forward Technology Festival events are free. Some require registration. Information about all of the events is at forwardfest.org .
For the original version including any supplementary images or video, visit http://www.jsonline.com/business/forward-technology-festival-draws-entrepreneurs-to-madison-b9978828z1-220292691.html
Teaching 150 teenagers the basics of technology in 6 weeks
Penney In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Aecom Technology Corp ( NYSE: ACM ) was identified as having a larger market cap than the smaller end of the S&P 500, for example J.C. Penney Co., Inc. ( NYSE: JCP ), according to The Online Investor . Click here to find out the top S&P 500 components ordered by average analyst rating Market capitalization is an important data point for investors to keep an eye on, for various reasons. The most basic reason is that it gives a true comparison of the value attributed by the stock market to a given companys stock. Many beginning investors look at one stock trading at $10 and another trading at $20 and mistakenly think the latter company is worth twice as much that of course is a completely meaningless comparison without knowing how many shares of each company exist. But comparing market capitalization (factoring in those share counts) creates a true apples-to-apples comparison of the value of two stocks. In the case of Aecom Technology Corp ( NYSE: ACM ), the market cap is now $2.94B, versus J.C. Penney Co., Inc. ( NYSE: JCP ) at $2.91B. Special Offer: Try OLI Premium and get reports on Splits, Buybacks, and M&A daily Another reason market capitalization is important is where it places a company in terms of its size tier in relation to peers much like the way a mid-size sedan is typically compared to other mid-size sedans (and not SUVs).
For the original version including any supplementary images or video, visit http://www.forbes.com/sites/dividendchannel/2013/08/19/aecom-technology-larger-than-sp-500-component-j-c-penney/
Technology Commercialization Group to Represent Optimapharm (CRO) in US Markets
Finance Tue, Aug 20, 2013, 7:42 AM EDT – U.S. Markets open in 1 hr 48 mins Breaking News Technology Commercialization Group to Represent Optimapharm (CRO) in US Markets Press Release: TCG 1 hour 42 minutes ago Related Content RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)– Technology Commercialization Group, LLC (TCG), a healthcare consultancy based in Research Triangle Park, North Carolina has signed an agreement to represent Optimapharm d.o.o., as it enters the US market. Optimapharm is a leading Southeastern European (SEE) based clinical research organization (CRO). The Company is headquartered in Zagreb, Croatia with additional offices in Belgrade, Serbia covering unique SEE clinical centers. Using their highly trained managers, Optimapharm has conducted more than 75 clinical studies since its inception in 2006 and serves six (6) SEE countries (Croatia, Slovenia, Serbia, Bosnia and Herzegovina, Montenegro and FYR Macedonia) as well as 22 other European countries through strategic partnerships. The agreement between Optimapharm and TCG enables us to offer high quality CRO services to US clients in a European Region not heavily burdened with competing clinical studies, said Gordana Greguric Cicak, MD, Chief Executive Officer of Optimapharm. We are the leading CRO in our region having extensive experience in Oncology, Psychiatry/Central Nervous System, Cardiovascular and Metabolic Diseases. Our highly trained investigators in six countries can deliver a naive treatment population of more than 25 million patients to US clinical researchers. We are very pleased to represent Optimapharm in the United States, said John Icardi, TCG Partner who will head the project. Croatia and Slovenia, being European Union members, gives US clients the confidence to contract with us, knowing we carefully operate to EMA and ICH/GCP standards. Our additional value however, is the limited number of clinical projects in the SEE Region and our unique ability to rapidly enroll qualified patients through highly motivated investigators. Optimapharm has trained many of those investigators. Optimapharm will be attending several US healthcare conferences this fall to introduce its experience and capabilities, beginning with BioPharm America in Boston in September 2013.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/technology-commercialization-group-represent-optimapharm-100000840.html